Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1 1

Status

Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5Sarcoma 1Breast 1

Conditions

Melanoma 37Lymphoma, T-Cell, Cutaneous 15Sezary Syndrome 14Mycosis Fungoides 14Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, B-Cell, Marginal Zone 11Hodgkin Disease 11Lymphoma, Mantle-Cell 10Lymphoma 10Burkitt Lymphoma 10Carcinoma, Merkel Cell 9Recurrence 8Leukemia, Myeloid, Acute 8Breast Neoplasms 8Skin Neoplasms 7Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Dendritic Cell Sarcoma, Interdigitating 7Primary Myelofibrosis 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Myelodysplastic Syndromes 6Leukemia, Myelomonocytic, Chronic 6

Interventions

HhAntag691 25Imiquimod 12Biopsy 12sonidegib 11Aminolevulinic Acid 9cemiplimab 8Photochemotherapy 8Nivolumab 8methyl 5-aminolevulinate 7Mohs Surgery 71-phenyl-3,3-dimethyltriazene 7Tomography, Optical Coherence 6Surgical Procedures, Operative 6Specimen Handling 5Radiotherapy 5Itraconazole 5pembrolizumab 4daromun 4Microscopy, Confocal 4Magnetic Resonance Spectroscopy 4Ipilimumab 4Curettage 4Standard of Care 3Niacinamide 3IPI-926 3CTLA-4 Antigen 33-ingenyl angelate 3tazarotene 2talimogene laherparepvec 2relatlimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × Radiotherapy × Dermatologic × Clear all
NCT05294120 2026-04-20

A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
38 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT04616248 2026-01-07

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

University of Southern California

Phase 1 Active not recruiting
14 enrolled
BreastDermatologicSarcoma

Bone Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Melanoma, Sarcoma, Osteosarcoma, Carcinoma, Merkel Cell

NCT05561634 2025-09-30

RADIOSONIC

University Hospital, Lille

Phase 2 Recruiting
82 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06384053 2025-06-15

SAHARA

Kantonsspital Winterthur KSW

Phase NA Recruiting
100 enrolled
Dermatologic

Hyperthermia, Carcinoma, Basal Cell

NCT02956889 2020-01-29

virgilio

Istituto Clinico Humanitas

Phase 2 Terminated
14 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡